PHIA Koninklijke Philips N.V.

Philips and Paracelsus Clinics enter into 8-year strategic partnership

Philips and Paracelsus Clinics enter into 8-year strategic partnership

March 2, 2020

Philips’ technology innovation, digitalization and AI-based analytics drive continuous process of sustainable transformation for Paracelsus Clinics

Amsterdam, the Netherlands & Osnabrück, Germany – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and , today announced they have entered into a strategic partnership for the next eight years. The partnership is focused on continuous modernization of Paracelsus Clinics’ medical imaging systems. Based on the evolving needs of the hospital, the partnership will offer solutions that maximize imaging system availability and standardize equipment operation, leveraging digitalization and process optimization to realize efficiency improvements while at the same time increasing quality.

“Paracelsus is committed to providing integrated care close to where people live in Germany,” said Dr. med. Dr. jur. Martin Siebert, CEO of Paracelsus Clinics. “With Philips, we now have a partner by our side who will support us in expanding this position and strengthen our future viability through its strengths in innovation and its digital competence. As an exclusive supplier, Philips will take care of new and replacement imaging system procurement, together with management and the training of our employees. The scope of delivery includes CT, MRI, angiography, X-ray and ultrasound systems. Philips offers the greatest possible flexibility in designing a tailor-made equipment pool that matches our changing requirements over time.”

“In addressing the challenges of the future, offering the latest technological innovations is only the first step,” said Peter Vullinghs, Senior Vice President, General Manager Philips GmbH Market DACH. "In our strategic partnership with Paracelsus we want to firmly anchor quality and efficiency as key success factors, not only at the structural level but also at the process level. It’s the only way we can achieve more together.”

“We were won over by the innovative concept for digitalization that Philips offered,” said Florian Distler, Head of the Procurement Management Office of Paracelsus Clinics. "This digital transformation will help us to better interlink outpatient, inpatient and rehabilitation at home.”

Artificial intelligence (AI) in leading-edge research

One of the intended lighthouse projects planned by Paracelsus and Philips will include installation of Philips’ Informatics AI Research Suite () in the Paracelsus Elena Clinic in Kassel – one of Germany’s leading clinics for the treatment of patients with Parkinson's disease and related movement disorders. Paracelsus intends to use the AI capabilities of Philips’ Informatics AI Research Suite () to further advance the internationally recognized cutting-edge research carried out by the clinic so that new findings on neurodegenerative diseases find their way into clinical care. Scientists can use the AI research platform to develop their own machine learning algorithms for specific questions. In addition, Philips will equip the clinic with innovative MR technology to support diagnosis and treatment in acute neurology care.

Standardization – key to cost efficiency

A team of consultants from Philips' Healthcare Transformation Services department, together with representatives from Paracelsus, have already initiated an optimization project for ultrasound imaging. Starting with a precise analysis of the current inventory, diagnostic capabilities, and the competitive environment at the Paracelsus Henstedt-Ulzburg, Reichenbach and Zwickau clinics, the team will develop recommendations for needs-based solutions with uniform operator interfaces. Where it involves ultrasound, the aim is to improve the level of ultrasound probe compatibility.

Improvement through proactive maintenance and performance measurement and analysis

Hospitals must be able to rely on medical technology always being ready for use. To ensure maximum availability, Philips will not only take responsibility for servicing its own technology at Paracelsus, but also that of third parties. Through a remote service that employs predictive analytics, potential issues can be identified and solved before downtime occurs.

Paracelsus also intends to leverage Philips’ Operational Informatics () to gain deep insights into the performance and utilization of its imaging solutions. The solution’s enterprise-wide workflow tools enables modality-specific analyzes as well as in-house and cross-company comparisons, allowing potential improvements to be identified and operational performance increased.

For further information, please contact:

Joost Maltha

Philips Global Press Office

Tel: 6

E-mail:

Kerstin Zimmermann

Philips DACH

Mobil: +49 (0) 171/81 80 186

E-mail:

Dirten von Schmeling

Paracelsus-Kliniken Deutschland GmbH & Co. KGaA 

Tel.: 333

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachments

EN
02/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 4T’25 Y CAMBIO DE P.O. AL ALZA (ANÁLISIS BANCO SABADELL...

Rdos. 4T’25 vs 4T’24: Ventas: 5.097 M euros (+1,1% vs -0,9% BS(e) y -1,0% consenso); EBITA Aj.: 770 M euros (+13,4% vs +0,6% BS(e) y -1,0% consenso); BDI: 397 M euros (-333 M euros en 2024 vs 275 M euros BS(e) y 276 M euros consenso); Rdos. 2025 vs 2024: Ventas: 17.834 M euros (-1,0% vs -1,6% BS(e) y -1,6% consenso); EBITA Aj.: 2.195 M euros (+5,7% vs +1,5% BS(e) y +1,0% consenso); BDI: 897 M euros (-698 M euros en 2024 vs 775 M euros BS(e) y 776 M euros consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch